SPBC215.11c Antibody

What is SPBC215.11c and why develop antibodies against it?

SPBC215.11c refers to a specific gene in Schizosaccharomyces pombe (fission yeast), encoding a protein that has been targeted for antibody development. Antibodies against this protein serve as important research tools for investigating protein expression, localization, and function in this model organism. S. pombe is widely used to study various aspects of eukaryotic biology due to its conserved regulatory processes and genetic features shared with metazoans .

The genome sequence of S. pombe contains numerous genes whose functions remain to be fully characterized, including SPBC215.11c. Researchers develop antibodies against these proteins to determine their subcellular localization, expression levels, and involvement in various cellular processes.

How are SPBC215.11c antibodies typically produced?

SPBC215.11c antibodies are generally produced through standard monoclonal or polyclonal antibody development processes. The typical methodology involves:

• Antigen preparation: Synthesizing peptides or expressing recombinant proteins representing SPBC215.11c

• Host immunization: Often using rabbits for polyclonal antibodies or mice for monoclonal antibodies

• Adjuvant selection: Frequently using Freund's Complete Adjuvant for initial immunization

• Antibody purification: Using affinity chromatography to isolate specific antibodies

• Validation: Confirming specificity through multiple techniques

For monoclonal antibody production, hybridoma technology remains common, although there is increasing emphasis on using more humane, in vitro alternative methods when possible .

What validation methods are essential for confirming SPBC215.11c antibody specificity?

Validation of SPBC215.11c antibodies requires a multi-faceted approach to ensure specificity and reliability:

As emphasized by The Antibody Society, "Demonstrating the selectivity of an antibody is an essential aspect of validation. Validation needs to be performed in each application where an antibody is used."

The gold standard negative control would be using S. pombe strains from the genome deletion project in which SPBC215.11c has been knocked out, as these deletion mutants now cover 99% of fission yeast open reading frames .

How can researchers troubleshoot non-specific binding of SPBC215.11c antibodies?

When encountering non-specific binding issues with SPBC215.11c antibodies, researchers should implement a systematic approach:

• Optimize blocking conditions by testing different blocking agents (BSA, milk, serum)

• Increase stringency of wash steps by adjusting salt concentration or detergent levels

• Perform pre-adsorption against lysates from SPBC215.11c deletion strains

• Titrate antibody concentration to find optimal signal-to-noise ratio

• Consider cross-reactivity with related proteins in the same family

The issue of antibody specificity is critical, as highlighted in multiple studies calling into question "the reliability of published data as the primary metric for assessing antibody quality" . Therefore, empirical validation in your specific experimental system is essential.

What are the optimal conditions for using SPBC215.11c antibodies in Western blotting?

For Western blotting applications with SPBC215.11c antibodies, the following protocol has shown optimal results:

• Sample preparation:

  • Harvest exponentially growing S. pombe cells (OD600 = 0.5-0.8)

  • Extract proteins using either TCA precipitation or mechanical disruption with glass beads

  • Include protease inhibitors to prevent degradation

• Electrophoresis and transfer:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Transfer to PVDF membranes at 100V for 60 minutes in standard transfer buffer

• Antibody incubation:

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with SPBC215.11c antibody at 1:1000 dilution overnight at 4°C

  • Wash 3 times with TBST for 10 minutes each

  • Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

• Detection:

  • Use enhanced chemiluminescence for visualization

  • Expected molecular weight may vary depending on post-translational modifications

These conditions should be optimized for each specific SPBC215.11c antibody lot, as "each antibody must be verified based on the content of the product sheet, and subsequently through experimentation to confirm integrity, specificity and selectivity" .

How can SPBC215.11c antibodies be used in ChIP-seq experiments to study gene regulation?

If SPBC215.11c is suspected to have DNA-binding properties or involvement in transcriptional regulation, ChIP-seq can be a valuable approach. Recent comprehensive studies have mapped the protein and chromatin interactions of numerous S. pombe transcription factors . For SPBC215.11c antibodies in ChIP-seq:

• Crosslinking and chromatin preparation:

  • Crosslink S. pombe cells with 1% formaldehyde for 15 minutes at room temperature

  • Quench with 125 mM glycine

  • Lyse cells and sonicate to generate 200-500 bp fragments

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Incubate with SPBC215.11c antibody (5-10 μg) overnight at 4°C

  • Include appropriate controls (IgG, input samples)

  • Capture complexes with protein A/G beads

• DNA recovery and library preparation:

  • Reverse crosslinks at 65°C overnight

  • Purify DNA using standard methods

  • Prepare sequencing libraries following platform-specific protocols

• Data analysis:

  • Map reads to the S. pombe genome

  • Identify enriched regions compared to input controls

  • Validate binding sites with additional techniques

The S. pombe TF study revealed "DNA binding sites across 2,027 unique genomic regions" for various transcription factors, providing a framework for investigating SPBC215.11c if it has DNA-binding properties .

How can SPBC215.11c antibodies be used to study protein-protein interactions in S. pombe?

Investigating protein-protein interactions involving SPBC215.11c can provide crucial insights into its biological function. The following methodologies are recommended:

• Co-immunoprecipitation (Co-IP):

  • Prepare native protein extracts from S. pombe cells

  • Immunoprecipitate with SPBC215.11c antibody

  • Analyze co-precipitated proteins by mass spectrometry

  • Confirm interactions with reciprocal Co-IPs

• Proximity-dependent labeling:

  • Generate fusion proteins of SPBC215.11c with BioID or APEX2

  • Express in S. pombe cells and activate labeling

  • Purify biotinylated proteins and identify by mass spectrometry

• Yeast two-hybrid screening:

  • Use SPBC215.11c as bait against S. pombe cDNA libraries

  • Validate positive interactions using co-IP or other methods

A recent study employing "immunoprecipitation-mass spectrometry" for S. pombe transcription factors "identified protein interactors for half the TFs, with over a quarter potentially forming stable complexes" . Similar approaches could reveal the interaction network of SPBC215.11c.

What strategies can be used to integrate SPBC215.11c antibody data with genome-wide studies?

Integrating SPBC215.11c antibody-generated data with genome-wide studies requires sophisticated bioinformatic approaches:

• Multi-omics data integration:

  • Combine ChIP-seq data (if applicable) with RNA-seq to correlate binding with gene expression

  • Integrate with proteomics data to understand post-transcriptional regulation

  • Compare with genetic interaction screens to place in functional pathways

• Network analysis:

  • Construct protein-protein interaction networks

  • Identify enriched biological processes and molecular functions

  • Map to known cellular pathways

• Comparative genomics:

  • Compare function with homologs in related yeast species

  • Investigate evolutionary conservation of interaction partners

• Data visualization:

  • Utilize genomic browsers to visualize binding profiles

  • Develop custom visualization tools for complex datasets

Recent work has created resources like "TFexplorer webtool" that "makes all data interactively accessible, offering new insights into TF interactions and regulatory mechanisms" . Similar approaches could be valuable for SPBC215.11c research.

How does SPBC215.11c gene deletion affect S. pombe phenotype, and how can antibodies confirm deletion?

The S. pombe genome deletion project has created "heterozygous diploid strains containing individual deletions in nearly all S. pombe genes" covering "99% of the fission yeast open reading frames" . For SPBC215.11c:

• Phenotypic analysis of deletion strains:

  • Assess growth rates in various media and conditions

  • Examine cell morphology, cell cycle progression, and stress responses

  • Test for genetic interactions with other deletions

• Confirmation of deletion using antibodies:

  • Western blotting of wild-type vs. deletion strain lysates

  • Immunofluorescence microscopy of wild-type vs. deletion strains

  • Detection of specific protein loss in deletion strains

• Complementation studies:

  • Reintroduce SPBC215.11c under native or inducible promoters

  • Confirm protein expression using antibodies

  • Assess rescue of mutant phenotypes

The deletion collection analysis has identified genes "that regulate fitness when cells are grown in a nutrient-rich environment compared with minimal environments" , providing a framework for understanding SPBC215.11c function.

How can researchers combine SPBC215.11c antibody approaches with nutrient response studies in S. pombe?

Given that S. pombe studies have identified genes "that regulate fitness when cells are grown in a nutrient-rich environment compared with minimal environments" , researchers can design experiments combining SPBC215.11c antibodies with nutrient response studies:

• Protein expression analysis across nutritional conditions:

  • Culture S. pombe in nutrient-rich versus minimal media

  • Analyze SPBC215.11c protein levels by Western blotting

  • Quantify changes in expression or post-translational modifications

• Subcellular localization in response to nutrients:

  • Perform immunofluorescence microscopy across nutritional conditions

  • Track changes in protein localization during nutrient shifts

  • Correlate with cellular stress responses

• Chromatin association during nutrient stress:

  • If SPBC215.11c has DNA-binding properties, perform ChIP-seq under different nutrient conditions

  • Identify condition-specific binding sites

  • Correlate with transcriptional changes

• Protein-protein interactions in nutrient response:

  • Compare SPBC215.11c interactome across nutritional conditions

  • Identify condition-specific interaction partners

  • Map to known nutrient signaling pathways

These approaches could reveal whether SPBC215.11c plays a role in "the coordination of growth and cell proliferation with the nutrient environment" .

What are the optimal storage conditions for maintaining SPBC215.11c antibody activity?

To ensure long-term stability and consistent performance of SPBC215.11c antibodies:

• Primary storage recommendations:

  • Store antibody aliquots at -20°C for long-term storage

  • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

  • For working solutions, store at 4°C with preservatives (0.02% sodium azide)

• Stability considerations:

  • Monitor antibody performance over time using consistent positive controls

  • Validate each new lot against previous lots using the same experimental conditions

  • Document batch-to-batch variations

• Preservation additives:

  • For long-term storage, consider adding stabilizers like BSA (0.1-1%)

  • For freeze protection, glycerol (30-50%) can be added

  • Note any additives in experimental documentation for reproducibility

• Quality control:

  • Periodically test activity against known positive samples

  • Maintain detailed records of antibody performance over time

These practices align with recommendations from The Antibody Society for maintaining antibody integrity and experimental reproducibility .

How can researchers ensure reproducibility when using different lots of SPBC215.11c antibodies?

Ensuring reproducibility across different antibody lots is crucial for reliable research findings:

• Lot-to-lot validation protocol:

  • Test each new lot in parallel with the previous lot

  • Use identical experimental conditions and samples

  • Document any performance differences

• Reference standards:

  • Maintain a set of reference samples with known reactivity

  • Compare new lot performance against these standards

  • Create a standardized scoring system for antibody performance

• Extended validation for new lots:

  • Perform specificity tests (Western blotting, immunoprecipitation)

  • Verify expected staining patterns in immunofluorescence

  • Test reactivity across a range of concentrations

• Documentation and reporting:

  • Maintain detailed records of lot numbers and performance characteristics

  • Include lot information in publications and reports

  • Share validation data with other researchers using the same antibody

These practices address the concern that "batch-to-batch variability of antibodies, as well as differences between antibody suppliers" contribute to the reproducibility crisis in scientific research .

How does SPBC215.11c antibody performance compare with antibodies against other S. pombe proteins?

When designing experiments, it's valuable to understand how SPBC215.11c antibodies compare with other S. pombe antibodies:

• Comparative specificity analysis:

  • Test cross-reactivity with related proteins

  • Compare background levels in Western blotting and immunofluorescence

  • Assess performance in complex samples versus purified proteins

• Application-specific comparisons:

  • For Western blotting: Compare sensitivity, linearity, and background

  • For immunofluorescence: Compare signal-to-noise ratio and localization specificity

  • For ChIP applications: Compare enrichment levels and specificity

• Standardized benchmarking:

  • Use standardized positive controls across different antibodies

  • Develop quantitative metrics for antibody performance

  • Create comparative performance profiles for different applications

This comparative analysis is essential as "each antibody must be verified based on the content of the product sheet, and subsequently through experimentation to confirm integrity, specificity and selectivity" .

What experimental design considerations are critical when planning studies using SPBC215.11c antibodies?

Robust experimental design is essential for generating reliable and meaningful data with SPBC215.11c antibodies:

• Controls framework:

  • Positive controls: Wild-type S. pombe expressing SPBC215.11c

  • Negative controls: SPBC215.11c deletion strains

  • Technical controls: Secondary antibody-only, isotype controls

  • Validation controls: Competing peptide blocking

• Sample preparation standardization:

  • Standardize growth conditions for S. pombe cultures

  • Document harvest points and cell densities

  • Use consistent lysis and protein extraction methods

• Quantification and statistical approach:

  • Define quantification methods before beginning experiments

  • Determine appropriate statistical tests for anticipated data

  • Calculate required sample sizes for adequate statistical power

• Replication strategy:

  • Include biological replicates (different cultures)

  • Include technical replicates (repeated measurements)

  • Plan for independent experimental validation of key findings

Such rigorous experimental design addresses concerns that "several studies have called into question the reliability of published data as the primary metric for assessing antibody quality" .

How might emerging antibody technologies improve SPBC215.11c research?

The field of antibody technology continues to evolve, offering new opportunities for SPBC215.11c research:

• Recombinant antibody development:

  • Generation of sequence-defined recombinant antibodies against SPBC215.11c

  • Engineering antibodies with improved specificity and affinity

  • Development of renewable antibody resources

• Advanced imaging applications:

  • Super-resolution microscopy for detailed localization studies

  • Live-cell imaging using fluorescent nanobodies

  • Correlative light and electron microscopy for ultrastructural localization

• Proximity labeling applications:

  • Antibody-mediated targeting of enzymatic tags for proximity labeling

  • Spatial proteomics to map SPBC215.11c microenvironments

  • In situ detection of protein-protein interactions

• Single-cell applications:

  • Single-cell proteomics with SPBC215.11c antibodies

  • Mass cytometry for high-dimensional protein profiling

  • Integration with single-cell genomics data

These approaches represent the frontier of antibody technology, providing "new insights into TF interactions and regulatory mechanisms with broad biological relevance" .

What bioinformatic resources are available to support SPBC215.11c antibody research?

Several bioinformatic resources can enhance SPBC215.11c antibody-based research:

• S. pombe specific databases:

  • PomBase: Comprehensive S. pombe genome database

  • TFexplorer: Interactive tool for exploring transcription factor data

  • S. pombe deletion mutant database: Resource for knockout strains

• Antibody-specific resources:

  • The Patent and Literature Antibody Database (PLAbDab): "An evolving reference set of functionally diverse, literature-annotated antibody sequences and structures"

  • Antibody validation repositories: Databases of validated antibodies and protocols

• Omics integration platforms:

  • Tools for integrating antibody-derived data with transcriptomics

  • Network analysis software for protein interaction mapping

  • Pathway enrichment tools for functional analysis

• Visualization resources:

  • Genome browsers adapted for S. pombe

  • Protein structure visualization tools

  • Interactive network visualization platforms

These resources provide researchers with "new insights into TF interactions and regulatory mechanisms with broad biological relevance" that can be applied to SPBC215.11c studies.